Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

NPPA Fixes Retail Prices for 28 Drug Formulations Including Dapagliflozin, Telmisartan, Amoxycillin, Details

Susmita Roy6 Nov 2025 11:38 PM IST

New Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of...

Dr. Reddy's Gets CDSCO Panel Nod for BE Study on Resmetirom Tablets for NASH Treatment

Susmita Roy6 Nov 2025 3:17 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to Dr. Reddy's...

Solara Active Pharma Swings to Rs 10.1 Crore Loss in Q2 FY26 Amid Shutdown Impact, Focuses on Deleveraging

Susmita Roy6 Nov 2025 2:41 PM IST

New Delhi: Solara Active Pharma Sciences Limited has reported a consolidated net loss of Rs 10.1 crore for the quarter ended September 30, 2025 (Q2...

NPPA Continues Price Cap on Orthopedic Knee Replacement Implants for Another Year Till November 15, 2026

Knee Implant Prices Under Fresh Review: NPPA Weighs 10% Hike Request from Manufacturers

Susmita Roy5 Nov 2025 9:58 PM IST

New Delhi: India's drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), is planning to review the ceiling prices of knee...

Delhi HC Rejects FMC Plea, Clears Natco to Launch Cyantraniliprole Ahead of Patent Expiry

Major Relief for SBSF College of Pharmacy: Delhi HC Orders PCI to Evaluate D.Pharm Affiliation

Susmita Roy5 Nov 2025 5:09 PM IST

New Delhi: In a major relief to SBSF College of Pharmacy, the Delhi High Court has directed the Pharmacy Council of India (PCI) to process and decide...

JnJ Darzalex faspro approved by USFDA for high risk smoldering multiple myeloma

CDSCO Panel Approves Updated Package Insert for Johnson and Johnson's Stelara

Susmita Roy5 Nov 2025 4:51 PM IST

New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended approval for the updated...

Maharashtra Faces Pharmacy Admission Slump Despite 38 New Colleges, Only 48% Students Confirm Seats

Susmita Roy5 Nov 2025 4:29 PM IST

Mumbai: Maharashtra's Bachelor of Pharmacy (B Pharm) admissions have once again hit a roadblock, with thousands of seats likely to go unfilled this...

CDSCO Panel Approves Updated Package Insert for Takeda's Vedolizumab

Susmita Roy5 Nov 2025 4:16 PM IST

New Delhi: In a key regulatory development, the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has...

CDSCO Panel Asks Shilpa Biologicals to Revise Phase III Protocol for Recombinant Human Serum Albumin Study

Susmita Roy4 Nov 2025 4:39 PM IST

New Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has sought major revisions in...

Low-Risk Medical Device Makers Get Clarity: CDSCO Publishes Class A Risk Classification List under MDR 2017

Susmita Roy3 Nov 2025 9:07 PM IST

New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has released a detailed Risk Classification List of Class A (non-sterile and...

PCI Announces Rs 12,400 Monthly Scholarship for GPAT-Qualified M.Pharm Students

Susmita Roy3 Nov 2025 8:22 PM IST

New Delhi: The Pharmacy Council of India (PCI), under the Ministry of Health and Family Welfare, Government of India, has announced the disbursement...

AstraZeneca Gets SEC Nod to Update Lokelma Prescribing Information for Hyperkalemia Treatment

Susmita Roy3 Nov 2025 7:08 PM IST

New Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has recommended approval for...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok